Medeon Biodesign, Inc. (6499.TWO)
TWD 39.6
(-1.0%)
TWD 39.6
(-1.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -755.07 Million | -461.34 Million | -293.37 Million | -151.27 Million | -241.98 Million |
| Net Income | -1.2 Billion | -439.11 Million | 2.12 Billion | -113.65 Million | -254.07 Million |
| Depreciation & Amortization | 95.66 Million | 63.8 Million | 59.01 Million | 84.27 Million | 79.25 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 15.69 Million | 3.1 Million | 5.95 Million | 504 Thousand | 7.18 Million |
| Change in working capital | 24.99 Million | 30.83 Million | 62.4 Million | -86.16 Million | -71.45 Million |
| Other non-cash items | 313.18 Million | -5.69 Million | -15.18 Million | -6.74 Million | -14.75 Million |
| Investing Cash Flow | 1.59 Billion | 263.43 Million | -90.63 Million | 245.62 Million | -320.66 Million |
| Investments in PPE | -55.28 Million | -140.71 Million | -9.01 Million | -21.15 Million | -51.32 Million |
| Acquisitions | 913 Thousand | -165.88 Million | 765.97 Million | - | - |
| Investment purchases | -255 Thousand | -29.72 Million | -846.76 Million | - | -395.16 Million |
| Sales/Maturities of investments | 1.64 Billion | 582.63 Million | - | 270.12 Million | 126.81 Million |
| Other Investing Activities | 1.65 Billion | -1.04 Million | -832 Thousand | -3.34 Million | -978 Thousand |
| Financing Cash Flow | -90.57 Million | -101.15 Million | -3.9 Million | 565.83 Million | 711.25 Million |
| Debt repayment | -47.88 Million | - | - | -12.93 Million | - |
| Dividends payments | -43.82 Million | -73.03 Million | - | -30.39 Million | -776 Thousand |
| Common Stock Repurchased | - | - | - | -20.47 Million | - |
| Common Stock Issuance | 225 Thousand | - | 10.09 Million | 80 Thousand | 662.82 Million |
| Other Financing Activities | 1.13 Million | 1.04 Million | 3.39 Million | 625.04 Million | 69.48 Million |
| Accounts receivables | -9.99 Million | 16.69 Million | - | - | - |
| Accounts payables | 1.42 Million | 2.87 Million | - | - | - |
| Inventory | -710 Thousand | -4.39 Million | -10.04 Million | -11.89 Million | -22.45 Million |
| Other working capital | 35.69 Million | 18.54 Million | - | - | - |
| Cash at beginning of period | 483.89 Million | 735.32 Million | 1.12 Billion | 472.05 Million | 328.11 Million |
| Cash at end of period | 1.23 Billion | 483.89 Million | 735.32 Million | 1.12 Billion | 472.05 Million |
| Capital Expenditure | -55.28 Million | -140.71 Million | -9.01 Million | -21.15 Million | -51.32 Million |
| Effect of forex changes on cash | 4.09 Million | 47.63 Million | -4.89 Million | -4.12 Million | -4.65 Million |
| Net cash flow / Change in cash | 754.06 Million | -251.42 Million | -392.8 Million | 656.06 Million | 143.94 Million |
| Free Cash Flow | -810.36 Million | -602.05 Million | -302.38 Million | -172.42 Million | -293.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -216.08 Million | -214.79 Million | -204.61 Million | -208.52 Million | -607.51 Million | -189.94 Million |
| Depreciation & Amortization | 23.98 Million | 23.17 Million | 23.99 Million | 24.5 Million | 24.89 Million | 22.28 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 2.95 Million | 3.71 Million | - | 3.65 Million | 4.09 Million | 3.78 Million |
| Change in working capital | 2.86 Million | 10.63 Million | 16.58 Million | -6.32 Million | 12.87 Million | 5.53 Million |
| Other non-cash items | -6.1 Million | -2.96 Million | -21.61 Million | -2.16 Million | -2.13 Million | -1.3 Million |
| Investing Cash Flow | -38.18 Million | 205.13 Million | -24.88 Million | -219 Million | 1.44 Billion | 389.8 Million |
| Investments in PPE | -21 Million | -22.32 Million | -8.22 Million | -7.15 Million | -35.83 Million | -4.49 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -255 Thousand | - | - |
| Sales/Maturities of investments | -17.2 Million | 227.69 Million | -17.4 Million | -212.01 Million | -1.38 Million | 394.17 Million |
| Other Investing Activities | 27 Thousand | -237 Thousand | 844 Thousand | 427 Thousand | -148 Thousand | 133 Thousand |
| Financing Cash Flow | -12.71 Million | -8.22 Million | -10.95 Million | -54.7 Million | -12.85 Million | -12.05 Million |
| Debt repayment | -12.71 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.84 Million | - | - | 125 Thousand | 100 Thousand |
| Other Financing Activities | -12.71 Million | - | -10.95 Million | 256 Thousand | - | 657 Thousand |
| Accounts receivables | -6.98 Million | - | 4.63 Million | - | - | - |
| Accounts payables | 7.94 Million | - | - | - | - | - |
| Inventory | -4.5 Million | -3.47 Million | -3.52 Million | 2.63 Million | 551 Thousand | -370 Thousand |
| Other working capital | 6.4 Million | - | 15.47 Million | - | - | - |
| Cash at beginning of period | 1.26 Billion | 1.23 Billion | 1.47 Billion | 1.92 Billion | 691.45 Million | 483.89 Million |
| Cash at end of period | 948.34 Million | 1.26 Billion | 1.23 Billion | 1.47 Billion | 1.92 Billion | 691.45 Million |
| Capital Expenditure | -21 Million | -22.32 Million | -8.22 Million | -7.15 Million | -35.83 Million | -4.49 Million |
| Effect of forex changes on cash | 1.49 Million | 5.64 Million | - | 4.67 Million | 12.26 Million | -1 Million |
| Net cash flow / Change in cash | -316.89 Million | 27.28 Million | -233.33 Million | -456.57 Million | 1.23 Billion | 207.55 Million |
| Free Cash Flow | -288.49 Million | -197.6 Million | -193.88 Million | -194.7 Million | -248.33 Million | -173.67 Million |
WDS
MAPB
GRC
MJD
FBU
PET